Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evolving enzyme technology for pharmaceutical applications: case studies

W K Yeh1

  • 1Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA.

Journal of Industrial Microbiology & Biotechnology
|February 6, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification and characterization of a monofunctional glycosyltransferase from Staphylococcus aureus.

Journal of bacteriology·2001
Same author

Purification, characterization, and kinetic mechanism of cyclin D1. CDK4, a major target for cell cycle regulation.

The Journal of biological chemistry·1998
Same author

Enzymatic synthesis of diastereospecific carbacephem intermediates using serine hydroxymethyltransferase.

Journal of industrial microbiology & biotechnology·1998
Same author

Biochemical characterization of penicillin-resistant and -sensitive penicillin-binding protein 2x transpeptidase activities of Streptococcus pneumoniae and mechanistic implications in bacterial resistance to beta-lactam antibiotics.

Journal of bacteriology·1997
Same author

Cloning and characterization of femA and femB from Staphylococcus epidermidis.

Gene·1996
Same author

Refolding and purification of Cephalosporium acremonium deacetoxycephalosporin C synthetase/hydroxylase from granules of recombinant Escherichia coli.

Biotechnology and applied biochemistry·1996
Same journal

Metabolic engineering of Escherichia coli for resveratrol production using food-grade D-xylose as a carbon source.

Journal of industrial microbiology & biotechnology·2026
Same journal

Proteome-wide analysis of protein stability in Escherichia coli under acid stress.

Journal of industrial microbiology & biotechnology·2026
Same journal

Engineering Escherichia coli to produce medium chain oleochemicals from C2 substrates.

Journal of industrial microbiology & biotechnology·2026
Same journal

Hybrid modeling for industrial fermentation processes with an "Intra-Batch Experimental Design".

Journal of industrial microbiology & biotechnology·2026
Same journal

Expanding the genetic toolset: using serine recombinases to integrate riboregulatory elements into industrially relevant microbial chassis.

Journal of industrial microbiology & biotechnology·2026
Same journal

Isolation and characterization of Saccharomyces cerevisiae mutants with ornithine accumulation for value-added craft beer brewing.

Journal of industrial microbiology & biotechnology·2026
See all related articles

Enzymes are key to pharmaceutical development. This study details enzyme applications for enhancing antibiotic biosynthesis and synthesizing novel drug compounds, improving drug production efficiency.

Area of Science:

  • Biotechnology
  • Enzyme Engineering
  • Pharmaceutical Sciences

Background:

  • Enzymes play critical roles in microbial biosynthesis pathways.
  • Optimizing enzyme function is crucial for improving the production of valuable pharmaceutical compounds.
  • Current methods for antibiotic and antifungal agent synthesis can be enhanced through enzymatic approaches.

Purpose of the Study:

  • To explore enzyme applications in pharmaceutical development, focusing on antibiotic biosynthesis and chemo-enzymatic synthesis.
  • To investigate the manipulation of specific enzymes for increased production of tylosin and cephalosporin C.
  • To demonstrate the utility of enzymes in the synthesis of carbacephem and echinandin B.

Main Methods:

  • Purification and characterization of key enzymes from Streptomyces fradiae and Cephalosporium acremonium.

Related Experiment Videos

  • Genetic manipulation and gene overexpression of rate-limiting enzymes to enhance antibiotic biosynthesis.
  • Heterologous expression of genes in microbial hosts to enable production of specific compounds.
  • Chemo-enzymatic synthesis strategies utilizing purified enzymes for novel drug development.

    • Main Results:

    • Successful purification and characterization of demethylmacrocin O-methyltransferase, macrocin O-methyltransferase, and tylosin reductase from S. fradiae.
    • Improved cephalosporin C biosynthesis in C. acremonium through overexpression of deacetoxycephalosporin C synthase/hydroxylase.
    • Demonstrated DAOC production in P. chrysogenum via heterologous expression of S. clavuligerus genes.
    • Successful chemo-enzymatic synthesis of carbacephem and echinandin B using specific enzymes.

    Conclusions:

    • Enzyme engineering and application are powerful tools for enhancing the biosynthesis of existing antibiotics.
    • Heterologous expression of key biosynthetic genes enables novel compound production in alternative hosts.
    • Chemo-enzymatic synthesis provides efficient routes for the development of new pharmaceutical agents.
    • These enzymatic strategies offer significant potential for optimizing pharmaceutical production and drug discovery.